[HTML][HTML] TIPARP as a prognostic biomarker and potential immunotherapeutic target in male papillary thyroid carcinoma
J Zhang, X Zhou, F Yao, JL Zhang, Q Li - Cancer Cell International, 2024 - Springer
Background Male patients with papillary thyroid carcinoma (PTC) tend to have poorer
prognosis compared to females, partially attributable to a higher rate of lymph node …
prognosis compared to females, partially attributable to a higher rate of lymph node …
TIPARP as a prognostic biomarker and potential immunotherapeutic target in male papillary thyroid carcinoma
J Zhang, X Zhou, F Yao, JL Zhang… - Cancer cell …, 2024 - pubmed.ncbi.nlm.nih.gov
Background Male patients with papillary thyroid carcinoma (PTC) tend to have poorer
prognosis compared to females, partially attributable to a higher rate of lymph node …
prognosis compared to females, partially attributable to a higher rate of lymph node …
TIPARP as a prognostic biomarker and potential immunotherapeutic target in male papillary thyroid carcinoma.
J Zhang, X Zhou, F Yao, JL Zhang… - Cancer Cell …, 2024 - search.ebscohost.com
Background: Male patients with papillary thyroid carcinoma (PTC) tend to have poorer
prognosis compared to females, partially attributable to a higher rate of lymph node …
prognosis compared to females, partially attributable to a higher rate of lymph node …
[HTML][HTML] TIPARP as a prognostic biomarker and potential immunotherapeutic target in male papillary thyroid carcinoma
J Zhang, X Zhou, F Yao, JL Zhang, Q Li - Cancer Cell International, 2024 - ncbi.nlm.nih.gov
Background Male patients with papillary thyroid carcinoma (PTC) tend to have poorer
prognosis compared to females, partially attributable to a higher rate of lymph node …
prognosis compared to females, partially attributable to a higher rate of lymph node …
TIPARP as a prognostic biomarker and potential immunotherapeutic target in male papillary thyroid carcinoma.
J Zhang, X Zhou, F Yao, Q Li - Cancer Cell International, 2024 - europepmc.org
Background Male patients with papillary thyroid carcinoma (PTC) tend to have poorer
prognosis compared to females, partially attributable to a higher rate of lymph node …
prognosis compared to females, partially attributable to a higher rate of lymph node …
[HTML][HTML] TIPARP as a prognostic biomarker and potential immunotherapeutic target in male papillary thyroid carcinoma
J Zhang, X Zhou, F Yao… - Cancer Cell …, 2024 - cancerci.biomedcentral.com
Male patients with papillary thyroid carcinoma (PTC) tend to have poorer prognosis
compared to females, partially attributable to a higher rate of lymph node metastasis (LNM) …
compared to females, partially attributable to a higher rate of lymph node metastasis (LNM) …
[PDF][PDF] TIPARP as a prognostic biomarker and potential immunotherapeutic target in male papillary thyroid carcinoma
J Zhang, X Zhou, F Yao, JL Zhang, Q Li - 2024 - cancerci.biomedcentral.com
Background Male patients with papillary thyroid carcinoma (PTC) tend to have poorer
prognosis compared to females, partially attributable to a higher rate of lymph node …
prognosis compared to females, partially attributable to a higher rate of lymph node …
TIPARP as a prognostic biomarker and potential immunotherapeutic target in male papillary thyroid carcinoma.
J Zhang, X Zhou, F Yao, Q Li - Cancer Cell International, 2024 - europepmc.org
Male patients with papillary thyroid carcinoma (PTC) tend to have poorer prognosis
compared to females, partially attributable to a higher rate of lymph node metastasis (LNM) …
compared to females, partially attributable to a higher rate of lymph node metastasis (LNM) …